| Basics |
Co-Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
|
| IPO Date: |
July 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$12.25M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 4.17%
|
| Avg Daily Range (30 D): |
$0.02 | 6.42%
|
| Avg Daily Range (90 D): |
$0.03 | 4.89%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.06M |
| Avg Daily Volume (30 D): |
.13M |
| Avg Daily Volume (90 D): |
.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
214 |
| Avg Trade Size (Sh.) (30 D): |
536 |
| Avg Trade Size (Sh.) (90 D): |
519 |
| Institutional Trades |
| Total Inst.Trades: |
441 |
| Avg Inst. Trade: |
$1.25M |
| Avg Inst. Trade (30 D): |
$.7M |
| Avg Inst. Trade (90 D): |
$.7M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.98M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
140.98K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-1.24
|
$-.36
|
$-1.24
|
|
Diluted EPS
|
$-1.24
|
$-.36
|
$-1.24
|
|
Revenue
|
$ 3.92M
|
$ .15M
|
$ 3.92M
|
|
Gross Profit
|
$ 2.92M
|
$ -.11M
|
$ 2.92M
|
|
Net Income / Loss
|
$ -37.64M
|
$ -11.03M
|
$ -37.64M
|
|
Operating Income / Loss
|
$ -40.08M
|
$ -11.91M
|
$ -40.08M
|
|
Cost of Revenue
|
$ 1M
|
$ .26M
|
$ 1M
|
|
Net Cash Flow
|
$ -11.98M
|
$ -11.98M
|
$ -11.98M
|
|
PE Ratio
|
|
|
|
|
